Anzeige
Mehr »
Login
Dienstag, 14.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Uran-Rallye: Preise ziehen wieder an - Jetzt nicht den Einstieg verpassen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema ARMATA PHARMACEUTICALS

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
MiArmata Pharmaceuticals GAAP EPS of -$0.69 misses by $0.38, revenue of $0.97M misses by $0.17M1
07.05.Armata Pharmaceuticals, Inc. - 10-Q, Quarterly Report1
07.05.Armata Pharmaceuticals, Inc. - 8-K, Current Report-
07.05.Armata Pharmaceuticals, Inc.: Armata Pharmaceuticals Announces First Quarter 2024 Results and Provides Corporate Update19LOS ANGELES, May 7, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on high-purity, pathogen-specific bacteriophage...
► Artikel lesen
21.03.Armata Pharmaceuticals reports Q4 results2
21.03.Armata Pharmaceuticals, Inc. - 10-K, Annual Report1
21.03.Armata Pharmaceuticals, Inc. - 8-K, Current Report1
21.03.Armata Pharmaceuticals, Inc.: Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update303LOS ANGELES, March 21, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on high-purity, pathogen-specific bacteriophage...
► Artikel lesen
04.03.Armata Pharmaceuticals, Inc. - 8-K, Current Report1
23.01.Armata Pharmaceuticals, Inc. - S-8, Securities to be offered to employees in employee benefit plans4